ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » General Practice

Top General Practice Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARGARET MEHLE M.D.

General Practice

15,110

$886K

612
485 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 21%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $57

SANDRA DIMMITT MD

General Practice

13,954

$672K

397
353 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $57

MAHA SULTAN M.D.

General Practice

12,891

$877K

376
253 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

40%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $57

STEPHEN FEUERBORN M.D.

General Practice

12,676

$712K

512
410 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $57

WILLIAM WILLIS M.D.

General Practice

11,870

$632K

410
193 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

42%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $57

JAMES TURRENTINE DO

General Practice

10,072

$598K

490
317 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

33%
patients receiving schedule three controlled substances

Avg: 21%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $57

KASH BIDDLE DO

General Practice

9,854

$566K

346
142 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

36%
patients receiving schedule three controlled substances

Avg: 21%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $57

RONALD HILL M.D.

General Practice

9,527

$539K

312
247 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

38%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $57

CHRIS MANSCHRECK DO

General Practice

9,095

$606K

317
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $57

BETH LEADER DO

General Practice

9,084

$428K

414
316 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $57

JOHN FRIEDL D.O.

General Practice

9,014

$753K

476
71 are 65+

89%
patients receiving schedule two controlled substances

Avg: 9%

29%
patients receiving schedule three controlled substances

Avg: 21%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $57

EDWIN ELLIS MD

General Practice

8,493

$428K

380
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $57

CHRISTOPHER EDGE D.O.

General Practice

7,680

$547K

320
232 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $57

DOUGLAS BRANT D.O.

General Practice

7,465

$406K

295
183 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

36%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $57

DAVID MILLER MD

General Practice

7,214

$483K

290
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $57

JOHN HESTER D.O.

General Practice

7,104

$308K

290
215 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $57

JOHN TATOM MD

General Practice

7,064

$248K

213
137 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $57

JESSE SULLIVAN MD

General Practice

6,881

$262K

413
317 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $57

CHIU TSAI MD

General Practice

6,718

$311K

193
167 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 21%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $57

RODNEY MCCRORY D.O.

General Practice

6,339

$572K

372
297 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $57

MARK ROGOW MD

General Practice

5,850

$329K

403
194 are 65+

35%
patients receiving schedule two controlled substances

Avg: 9%

35%
patients receiving schedule three controlled substances

Avg: 21%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $57

JAMES KNECHT D.O.

General Practice

5,398

$250K

337
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $57

RITA WESTENHAVER DO

General Practice

5,183

$203K

145
84 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 21%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $57

SOLOMON ALI M.D.

General Practice

4,732

$222K

197
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

23%
patients receiving schedule three controlled substances

Avg: 21%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $57

NEAL SUTHERS MD

General Practice

4,359

$192K

237
195 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 21%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank